Navalkar R G, Deshpande R G, Khan M B, Savariar L S, Navalkar S R
Department of Microbiology and Immunology, Morehouse School of Medicine, Atlanta, Georgia 30310.
Int J Lepr Other Mycobact Dis. 1992 Sep;60(3):382-9.
A low molecular weight protein was obtained from a sonicate of armadillo-derived Mycobacterium leprae cells and from a lambda gt11 phage lysate of Escherichia coli (specifying the M. leprae 12-kDa protein) by a single step of ultrafiltration. Both proteins had an approximate molecular weight of about 12,000 (by SDS-PAGE) and were recognized by the M. leprae 12-kDa-specific monoclonal antibody ML06 by immunoblotting. Sera from 79 leprosy patients across the clinical spectrum, 17 contacts, and 12 normal healthy individuals were screened in an enzyme-linked immunosorbent assay (ELISA) using the 12-kDa proteins as the antigens. Antibodies to the 12-kDa protein (from lysate as well as sonicate) were detected in patients' sera across the clinical spectrum (44%-100% positivity), while no detectable reactivity was observed with control or contact sera. Sera from patients who had undergone a year or more of chemotherapy exhibited no reactivity compared to those from patients with only 3-6 months of chemotherapy. The 12-kDa proteins were also recognized by rabbit hyper-immune M. leprae antiserum.
通过一步超滤法,从犰狳源麻风分枝杆菌细胞的超声裂解物以及大肠杆菌的λgt11噬菌体裂解物(指定为麻风分枝杆菌12 kDa蛋白)中获得了一种低分子量蛋白质。两种蛋白质的分子量约为12,000(通过SDS-PAGE),并且通过免疫印迹法被麻风分枝杆菌12 kDa特异性单克隆抗体ML06识别。使用12 kDa蛋白作为抗原,在酶联免疫吸附测定(ELISA)中对79名不同临床类型的麻风患者、17名接触者和12名正常健康个体的血清进行了筛查。在不同临床类型的患者血清中均检测到了针对12 kDa蛋白(来自裂解物以及超声裂解物)的抗体(阳性率为44%-100%),而对照血清或接触者血清未观察到可检测到的反应性。与仅接受3-6个月化疗的患者相比,接受一年或更长时间化疗的患者血清未表现出反应性。12 kDa蛋白也被兔抗麻风分枝杆菌超免疫血清识别。